Key result
NHE-1 inhibition with BIIB 513 was more efficacious than ischemic preconditioning at reducing infarct size after a 90-minute ischemic insult (P<0.05).
Why the study?
Does NHE-1 inhibition reduce infarct size more effectively than ischemic preconditioning in a canine model of myocardial ischemia?
Population
Canine infarct model undergoing 60- or 90-minute coronary artery occlusion followed by 3 hours of reperfusion
Comparison
Specific NHE-1 inhibitor BIIB 513 administered… vs Ischemic preconditioning produced by 1 or four…
Design
Preclinical
Follow-up
3 hours of reperfusion
Authors
Loading...
Should not change clinical practice; leaves open translation of NHE-1 inhibition to human cardioprotection trials.
Does NHE-1 inhibition reduce infarct size more effectively than ischemic preconditioning in a canine model of myocardial ischemia?
p-value: p=<0.05
NHE-1 inhibition provides greater cardioprotection than ischemic preconditioning against prolonged (90-minute) myocardial ischemia in a canine model, and their combination yields greater-than-additive benefits.
Gumina et al. (1999) studied Myocardial ischemia. NHE-1 inhibitor BIIB 513 vs. Ischemic preconditioning (IPC) was evaluated on Infarct size as a percentage of the area at risk (IS/AAR) (p=<0.05). NHE-1 inhibition with BIIB 513 was more efficacious than ischemic preconditioning at reducing infarct size after a 90-minute ischemic insult (P<0.05).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: